Results 11 to 20 of about 21,425 (243)

Thymoma with Autoimmune Hemolytic Anemia

open access: yesCase Reports in Oncology, 2014
A 38-year-old Japanese male was referred to our hospital with abnormal chest X-ray results and severe Coombs-positive hemolytic anemia. He was diagnosed with a stage IV, WHO type A thymoma and was treated with oral prednisolone (1 mg/kg/day) and ...
Kensuke Suzuki   +4 more
doaj   +4 more sources

Babesiosis-induced warm autoimmune hemolytic anemia, from infection to hemolysis: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Warm autoimmune hemolytic anemia is characterized by destruction of red blood cells mediated by autoantibodies, which can be triggered by various underlying factors including tick-borne infections. Babesia spp.
Jenna Davison   +6 more
doaj   +2 more sources

Immunotherapy-associated autoimmune hemolytic anemia

open access: yesJournal for ImmunoTherapy of Cancer, 2017
Background Immunotherapy has been widely used in the treatment of several solid and hematologic malignancies. Checkpoint inhibitors have been the forefront of cancer immunotherapy in recent years.
Uqba Khan   +4 more
doaj   +2 more sources

Cold versus warm autoimmune hemolytic anemia in diffuse large B cell lymphoma: pathogenic and therapeutic implications: a case series [PDF]

open access: yesJournal of Medical Case Reports
Background Autoimmune hemolytic anemia-associated diffuse large B cell lymphoma is rare, with distinct pathogenic mechanisms and therapeutic responses in cold agglutinin syndrome (CAS) and warm autoimmune hemolytic anemia subtypes poorly characterized ...
Zhiye Zhang   +3 more
doaj   +2 more sources

Autoimmune hemolytic anemia

open access: yesCurrent Opinion in Immunology, 1994
Autoimmune hemolytic anemia (AHA) is characterized by the production of Coombs' antibodies, which are responsible for the destruction of red blood cells (RBCs). Analysis of both monoclonal anti-RBC autoantibodies derived from autoimmune New Zealand black
Izui, Shozo
core   +4 more sources

Pancytopenia with autoimmune hemolytic anemia

open access: yesApollo Medicine, 2021
Payal Bargujar   +2 more
doaj   +2 more sources

Autoimmune hemolytic anemia [PDF]

open access: yesHematology, 2018
AbstractThe diagnosis of autoimmune hemolytic anemia (AIHA) can be made with a stepwise approach that aims to identify laboratory and clinical evidence of hemolysis and then determine the immune nature of hemolysis with the direct anti-globulin test. Once alternative causes for these findings have been excluded, AIHA is established, and the clinician ...
Anita, Hill, Quentin A, Hill
openaire   +5 more sources

Management of autoimmune hemolytic anemia. [PDF]

open access: yesHematology Am Soc Hematol Educ Program
Abstract Autoimmune hemolytic anemia (AIHA) is caused by premature erythrocyte destruction mediated by autoantibodies (auto-Ab) with or without complement activation. The most frequent form (60%-70% of cases) is warm AIHA (wAIHA), driven by immunoglobulin G auto-Ab that react at body temperature. Cold agglutinin disease (CAD, 20%-25%)
Barcellini W, Fattizzo B.
europepmc   +3 more sources

Acute Tubular Necrosis Associated with Autoimmune Hemolytic Anemia due to Acute Gastroenteritis

open access: yesTurkish Journal of Internal Medicine, 2021
Autoimmune hemolytic anemia (AIHA) is a rare disease with a rate of 1-3 in 100,000 in adults. AIHA are defined as primary (idiopathic) or secondary depending on the presence or absence of accompanying disease.
Mehmet Sezen   +7 more
doaj   +1 more source

Atypical autoimmune hemolytic anemia

open access: yesHaematologica, 2011
9/L (10-90), bilirubin 1.5 mg/dL (0-1.0), lactate dehydrogenase 1715 U/L (normal < 210) and ferritin 697 ng/mL. The blood film showed microcytosis and coarse basophilic stippling consistent with β-thalassemia trait. Only very occasional spherocytes were noted and there was no agglutination.
David Telio   +4 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy